Keith Katkin - Insider Trading & Ownership

Entity
Individual
Location
C/O Urovant Sciences, Inc., 5281 California Avenue, Suite 100, Irvine, CA
Summary
The estimated net worth of Keith Katkin is at least $1.58M dollars as of May 28, 2024. Keith Katkin is the Director of Syndax Pharmaceuticals Inc and owns shares of Syndax Pharmaceuticals Inc (SNDX) stock worth about $1.19M. Keith Katkin is the Director of Emergent BioSolutions Inc. and owns shares of Emergent BioSolutions Inc. (EBS) stock worth about $346K. Keith Katkin is the Director of RIGEL PHARMACEUTICALS INC and owns shares of RIGEL PHARMACEUTICALS INC (RIGL) stock worth about $43.8K.
All Insider Reports
All Insider Reports

Ownership of Keith Katkin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SNDX Syndax Pharmaceuticals Inc Director $1.19M Feb 7, 2024
EBS Emergent BioSolutions Inc. Director $346K May 23, 2024
RIGL RIGEL PHARMACEUTICALS INC Director $43.8K May 19, 2021
ELDN Eledon Pharmaceuticals, Inc. Director May 1, 2023

Insider Transactions Reported by Keith Katkin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.